Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
2.00
-0.10 (-4.76%)
At close: May 09, 2025, 3:59 PM
1.95
-2.26%
After-hours: May 09, 2025, 04:14 PM EDT
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Inhibikase Therapeutics generated $26.27K in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
15
Market Cap
148.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|